Literature DB >> 8759319

X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 A resolution.

S C Mosimann1, D L Newton, R J Youle, M N James.   

Abstract

The X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin (rEDN) has been determined by molecular replacement methods and refined at 1.83 A resolution to a conventional R-factor ( = sigma magnitute of (magnitute of F(zero)-magnitude of Fc)/ sigma magnitude of F(zero) of 0.152 with excellent stereochemistry. The molecular model of rEDN contains all 1081 non-hydrogen protein atoms, two non-covalently bound sulfate anions and 121 ordered solvent molecules. The polypeptide fold of rEDN is related to those observed in the homologous structures of RNase A, Onconase and angiogenin. rEDN is one of the largest members of the pyrimidine-specific ribonuclease superfamily of vertebrates and has small insertions in four of its seven loop structures and a large insertion from Asp115 to Tyr123. The non-covalently bound SO4(A) and SO4(B) anions occupy phosphate-binding subsites of rEDN. The active site SO4(A) anion makes contacts in rEDN that are similar to those in RNase A and involve the side-chain atoms of Gln14, His15 and His129, and the NH group of Leu130. The SO4(B) anion makes contacts with the side-chain atoms of Arg36 and Asn39 and the main-chain atoms of Asn39 and Gln40. The equivalent residues of RNase A cannot make contacts similar to those observed in rEDN. The SO4(B) binding site of rEDN likely corresponds to the P-1 subsite and may be representative of how other homologous RNases bind the P-1 phosphate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759319     DOI: 10.1006/jmbi.1996.0420

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates.

Authors:  Jianzhi Zhang; Helene F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity.

Authors:  H F Rosenberg; K D Dyer
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

3.  Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.

Authors:  A C Papageorgiou; R Shapiro; K R Acharya
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

4.  Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin.

Authors:  Donald Gagné; Chitra Narayanan; Khushboo Bafna; Laurie-Anne Charest; Pratul K Agarwal; Nicolas Doucet
Journal:  Biomol NMR Assign       Date:  2017-03-07       Impact factor: 0.746

5.  Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.

Authors:  C Z Chen; R Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 6.  Designing immunotoxins for cancer therapy.

Authors:  Christopher A Pennell; Heidi A Erickson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  Recognition signal for C-mannosylation of Trp-7 in RNase 2 consists of sequence Trp-x-x-Trp.

Authors:  J Krieg; S Hartmann; A Vicentini; W Gläsner; D Hess; J Hofsteenge
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

8.  Protein C-mannosylation is enzyme-catalysed and uses dolichyl-phosphate-mannose as a precursor.

Authors:  M A Doucey; D Hess; R Cacan; J Hofsteenge
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

9.  Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.

Authors:  De Yang; Qian Chen; Helene F Rosenberg; Susanna M Rybak; Dianne L Newton; Zhao Yuan Wang; Qin Fu; Velizar T Tchernev; Minjuan Wang; Barry Schweitzer; Stephen F Kingsmore; Dhavalkumar D Patel; Joost J Oppenheim; O M Zack Howard
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

10.  When is mass spectrometry combined with affinity approaches essential? A case study of tyrosine nitration in proteins.

Authors:  Brînduşa-Alina Petre; Martina Ulrich; Mihaela Stumbaum; Bogdan Bernevic; Adrian Moise; Gerd Döring; Michael Przybylski
Journal:  J Am Soc Mass Spectrom       Date:  2012-08-21       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.